Literature DB >> 14744434

Principles of tumor suppression.

Charles J Sherr1.   

Abstract

Molecular genetic studies of familial cancer syndromes identified and defined the recessive nature of tumor suppressor genes and resolved the paradox of why tumors arising in such families exhibited an autosomally dominant pattern of inheritance. Subsequent characterization of tumor suppressor proteins revealed their widespread involvement in sporadic cancers and pinpointed key mechanisms that protect animals against tumor development. We now recognize that tumor suppressor genes regulate diverse cellular activities, including cell cycle checkpoint responses, detection and repair of DNA damage, protein ubiquitination and degradation, mitogenic signaling, cell specification, differentiation and migration, and tumor angiogenesis. Their study has become a centerpiece of contemporary cancer research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744434     DOI: 10.1016/s0092-8674(03)01075-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  295 in total

Review 1.  Using mice to examine p53 functions in cancer, aging, and longevity.

Authors:  Lawrence A Donehower
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11-04       Impact factor: 10.005

2.  The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer.

Authors:  Z Gu; F Zhang; Z-Q Wang; W Ma; R E Davis; Z Wang
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

3.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.

Authors:  Susan M Bailey; Mark A Brenneman; Edwin H Goodwin
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

4.  Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.

Authors:  Philipp G Hemmati; Annika Müer; Bernd Gillissen; Tim Overkamp; Ana Milojkovic; Jana Wendt; Bernd Dörken; Peter T Daniel
Journal:  J Mol Med (Berl)       Date:  2010-04-25       Impact factor: 4.599

5.  Functional characterization of a cancer causing mutation in human replication protein A.

Authors:  Cathy S Hass; Lokesh Gakhar; Marc S Wold
Journal:  Mol Cancer Res       Date:  2010-06-29       Impact factor: 5.852

6.  NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Authors:  Tsutomu Mori; Daisuke D Ikeda; Toshihiko Fukushima; Seiichi Takenoshita; Hideo Kochi
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

7.  Evaluation of cyclin D1 expression and its subcellular distribution in mouse tissues.

Authors:  Maria De Falco; Valentina Fedele; Luca De Luca; Roberta Penta; Giuliano Cottone; Ivan Cavallotti; Vincenza Laforgia; Antonio De Luca
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

8.  Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.

Authors:  Yan Liu; Fan Liu; Hao Yu; Xinyang Zhao; Goro Sashida; Anthony Deblasio; Michael Harr; Qing-Bai She; Zhenbang Chen; Hui-Kuan Lin; Silvana Di Giandomenico; Shannon E Elf; Youyang Yang; Yasuhiko Miyata; Gang Huang; Silvia Menendez; Ingo K Mellinghoff; Neal Rosen; Pier Paolo Pandolfi; Cyrus V Hedvat; Stephen D Nimer
Journal:  Sci Signal       Date:  2012-10-23       Impact factor: 8.192

9.  Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.

Authors:  Helen Court; Marc Amoyel; Michael Hackman; Kyoung Eun Lee; Ruliang Xu; George Miller; Dafna Bar-Sagi; Erika A Bach; Martin O Bergö; Mark R Philips
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

10.  lin-35/Rb and the CoREST ortholog spr-1 coordinately regulate vulval morphogenesis and gonad development in C. elegans.

Authors:  Aaron M Bender; Natalia V Kirienko; Sara K Olson; Jeffery D Esko; David S Fay
Journal:  Dev Biol       Date:  2006-10-05       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.